rs61730545

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_170606.3(KMT2C):​c.9245C>T​(p.Pro3082Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00197 in 1,605,798 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P3082T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 3 hom., cov: 31)
Exomes 𝑓: 0.0021 ( 68 hom. )

Consequence

KMT2C
NM_170606.3 missense

Scores

5
8
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 8.07

Publications

20 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0094693005).
BP6
Variant 7-152176208-G-A is Benign according to our data. Variant chr7-152176208-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 134778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00118 (180/152282) while in subpopulation SAS AF = 0.0222 (107/4826). AF 95% confidence interval is 0.0188. There are 3 homozygotes in GnomAd4. There are 109 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 180 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2CNM_170606.3 linkc.9245C>T p.Pro3082Leu missense_variant Exon 38 of 59 ENST00000262189.11 NP_733751.2 Q8NEZ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2CENST00000262189.11 linkc.9245C>T p.Pro3082Leu missense_variant Exon 38 of 59 1 NM_170606.3 ENSP00000262189.6 Q8NEZ4-1

Frequencies

GnomAD3 genomes
AF:
0.00121
AC:
184
AN:
152164
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0230
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00378
AC:
928
AN:
245804
AF XY:
0.00470
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.000149
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00164
Gnomad NFE exome
AF:
0.000681
Gnomad OTH exome
AF:
0.00118
GnomAD4 exome
AF:
0.00205
AC:
2986
AN:
1453516
Hom.:
68
Cov.:
33
AF XY:
0.00276
AC XY:
1996
AN XY:
722418
show subpopulations
African (AFR)
AF:
0.000121
AC:
4
AN:
33038
American (AMR)
AF:
0.000138
AC:
6
AN:
43608
Ashkenazi Jewish (ASJ)
AF:
0.0000391
AC:
1
AN:
25572
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39558
South Asian (SAS)
AF:
0.0264
AC:
2249
AN:
85184
European-Finnish (FIN)
AF:
0.00164
AC:
87
AN:
53186
Middle Eastern (MID)
AF:
0.00280
AC:
16
AN:
5724
European-Non Finnish (NFE)
AF:
0.000444
AC:
492
AN:
1107744
Other (OTH)
AF:
0.00217
AC:
130
AN:
59902
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
155
310
465
620
775
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00118
AC:
180
AN:
152282
Hom.:
3
Cov.:
31
AF XY:
0.00146
AC XY:
109
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41546
American (AMR)
AF:
0.0000654
AC:
1
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0222
AC:
107
AN:
4826
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000544
AC:
37
AN:
68026
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000924
Hom.:
5
Bravo
AF:
0.000533
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00440
AC:
534
Asia WGS
AF:
0.00924
AC:
32
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2C: PM5, BS1, BS2 -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Benign
-0.093
T
BayesDel_noAF
Uncertain
0.11
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.50
T;T
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.94
.;D
MetaRNN
Benign
0.0095
T;T
MetaSVM
Uncertain
0.55
D
MutationAssessor
Benign
2.0
M;M
PhyloP100
8.1
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-5.2
D;D
REVEL
Uncertain
0.60
Sift
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.80
MVP
0.64
MPC
0.45
ClinPred
0.085
T
GERP RS
6.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.42
gMVP
0.53
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61730545; hg19: chr7-151873293; COSMIC: COSV51485941; COSMIC: COSV51485941; API